Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amino Acid Metabolism, Inborn Errors | 45 | 2024 | 284 | 13.060 |
Why?
|
Succinate-Semialdehyde Dehydrogenase | 51 | 2024 | 96 | 12.500 |
Why?
|
Epilepsy | 70 | 2024 | 3317 | 7.430 |
Why?
|
Developmental Disabilities | 37 | 2024 | 1519 | 5.660 |
Why?
|
gamma-Aminobutyric Acid | 29 | 2024 | 1139 | 3.650 |
Why?
|
Spasms, Infantile | 13 | 2023 | 300 | 3.380 |
Why?
|
Metabolism, Inborn Errors | 8 | 2021 | 291 | 2.200 |
Why?
|
Electroencephalography | 55 | 2024 | 6274 | 2.130 |
Why?
|
Brain Diseases, Metabolic, Inborn | 8 | 2011 | 46 | 2.120 |
Why?
|
Seizures | 39 | 2024 | 2997 | 1.980 |
Why?
|
Neurology | 8 | 2024 | 784 | 1.900 |
Why?
|
Pyridoxine | 8 | 2022 | 108 | 1.890 |
Why?
|
Anticonvulsants | 17 | 2024 | 1919 | 1.510 |
Why?
|
4-Aminobutyrate Transaminase | 3 | 2019 | 13 | 1.440 |
Why?
|
Epilepsies, Partial | 8 | 2023 | 431 | 1.410 |
Why?
|
Hydroxybutyrates | 8 | 2018 | 75 | 1.330 |
Why?
|
Neurotransmitter Agents | 7 | 2018 | 663 | 1.300 |
Why?
|
Child | 128 | 2024 | 80509 | 1.260 |
Why?
|
Metabolic Diseases | 3 | 2024 | 687 | 1.250 |
Why?
|
Bioethics | 2 | 2020 | 118 | 1.240 |
Why?
|
Sodium Oxybate | 4 | 2023 | 36 | 1.230 |
Why?
|
Vigabatrin | 5 | 2021 | 88 | 1.220 |
Why?
|
Hemiplegia | 2 | 2022 | 136 | 1.200 |
Why?
|
Epilepsies, Myoclonic | 4 | 2023 | 83 | 1.030 |
Why?
|
Aldehyde Oxidoreductases | 7 | 2004 | 88 | 1.020 |
Why?
|
Magnetoencephalography | 12 | 2024 | 585 | 1.010 |
Why?
|
Pyridoxaminephosphate Oxidase | 3 | 2017 | 8 | 0.880 |
Why?
|
Aromatic-L-Amino-Acid Decarboxylases | 4 | 2023 | 27 | 0.830 |
Why?
|
Child, Preschool | 61 | 2024 | 42478 | 0.820 |
Why?
|
Pediatrics | 7 | 2024 | 3602 | 0.820 |
Why?
|
Societies, Medical | 6 | 2024 | 3950 | 0.810 |
Why?
|
Hemispherectomy | 4 | 2023 | 40 | 0.780 |
Why?
|
Aldehyde Dehydrogenase | 4 | 2022 | 146 | 0.770 |
Why?
|
Humans | 222 | 2024 | 765823 | 0.750 |
Why?
|
Magnetic Resonance Imaging | 46 | 2024 | 36542 | 0.740 |
Why?
|
Adolescent | 74 | 2024 | 88794 | 0.670 |
Why?
|
Brain | 33 | 2024 | 27178 | 0.670 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2022 | 479 | 0.650 |
Why?
|
Physician Executives | 1 | 2020 | 140 | 0.640 |
Why?
|
Congresses as Topic | 2 | 2021 | 811 | 0.630 |
Why?
|
Infant | 46 | 2024 | 36375 | 0.630 |
Why?
|
Lysine | 2 | 2022 | 993 | 0.620 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2021 | 171 | 0.620 |
Why?
|
Receptors, GABA-A | 2 | 2016 | 623 | 0.620 |
Why?
|
Piracetam | 3 | 2013 | 88 | 0.610 |
Why?
|
Brain Waves | 5 | 2024 | 417 | 0.610 |
Why?
|
Speech | 2 | 2021 | 556 | 0.600 |
Why?
|
Intelligence | 2 | 2023 | 922 | 0.600 |
Why?
|
Leadership | 3 | 2024 | 1391 | 0.600 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2024 | 1884 | 0.590 |
Why?
|
Genetic Association Studies | 4 | 2021 | 2741 | 0.590 |
Why?
|
Brain Diseases, Metabolic | 2 | 2017 | 44 | 0.580 |
Why?
|
Pandemics | 4 | 2020 | 8698 | 0.560 |
Why?
|
Cerebellum | 3 | 2020 | 1519 | 0.550 |
Why?
|
Advisory Committees | 1 | 2021 | 796 | 0.550 |
Why?
|
Retinal Degeneration | 1 | 2021 | 413 | 0.550 |
Why?
|
Thyroid Hormones | 2 | 2018 | 409 | 0.540 |
Why?
|
Glutamate-tRNA Ligase | 1 | 2016 | 2 | 0.530 |
Why?
|
Mutation, Missense | 6 | 2024 | 2586 | 0.530 |
Why?
|
Auditory Perception | 1 | 2021 | 587 | 0.520 |
Why?
|
Phenotype | 17 | 2023 | 16706 | 0.490 |
Why?
|
Transcranial Magnetic Stimulation | 4 | 2022 | 1496 | 0.490 |
Why?
|
Brain Edema | 2 | 2018 | 601 | 0.490 |
Why?
|
Periodicity | 1 | 2016 | 347 | 0.490 |
Why?
|
De Lange Syndrome | 1 | 2015 | 22 | 0.480 |
Why?
|
Flumazenil | 2 | 2017 | 84 | 0.470 |
Why?
|
Motor Cortex | 4 | 2022 | 1003 | 0.470 |
Why?
|
Interprofessional Relations | 1 | 2020 | 998 | 0.450 |
Why?
|
Male | 103 | 2024 | 363740 | 0.450 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2017 | 361 | 0.450 |
Why?
|
Chorea | 1 | 2014 | 80 | 0.440 |
Why?
|
Dyslexia | 1 | 2015 | 215 | 0.440 |
Why?
|
Taurine | 1 | 2014 | 91 | 0.430 |
Why?
|
Female | 107 | 2024 | 396050 | 0.430 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2013 | 40 | 0.420 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 2013 | 74 | 0.420 |
Why?
|
GTP Cyclohydrolase | 1 | 2013 | 47 | 0.410 |
Why?
|
Leukoencephalopathies | 1 | 2016 | 259 | 0.410 |
Why?
|
Monoamine Oxidase | 1 | 2013 | 179 | 0.400 |
Why?
|
Suicide | 1 | 2023 | 1606 | 0.400 |
Why?
|
Nervous System Diseases | 3 | 2009 | 1658 | 0.390 |
Why?
|
Brain Mapping | 14 | 2023 | 6598 | 0.390 |
Why?
|
Psychomotor Disorders | 1 | 2013 | 149 | 0.390 |
Why?
|
Practice Guidelines as Topic | 5 | 2024 | 7416 | 0.390 |
Why?
|
Phenylketonurias | 1 | 2013 | 128 | 0.380 |
Why?
|
Critical Illness | 3 | 2021 | 2745 | 0.370 |
Why?
|
Health Surveys | 1 | 2021 | 4058 | 0.370 |
Why?
|
Family | 3 | 2021 | 3208 | 0.370 |
Why?
|
Music | 2 | 2015 | 249 | 0.370 |
Why?
|
Sequence Deletion | 1 | 2015 | 1493 | 0.360 |
Why?
|
Vitamins | 3 | 2024 | 1631 | 0.350 |
Why?
|
Monitoring, Physiologic | 4 | 2021 | 1794 | 0.350 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2011 | 113 | 0.350 |
Why?
|
Genetics | 1 | 2011 | 114 | 0.350 |
Why?
|
Brain Injuries | 5 | 2020 | 2061 | 0.350 |
Why?
|
Infant, Newborn | 20 | 2023 | 26337 | 0.350 |
Why?
|
Young Adult | 33 | 2024 | 59849 | 0.350 |
Why?
|
Norepinephrine | 1 | 2013 | 898 | 0.340 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2013 | 269 | 0.340 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 7 | 2005 | 3718 | 0.330 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2009 | 57 | 0.330 |
Why?
|
Knowledge | 1 | 2011 | 178 | 0.330 |
Why?
|
Phytotherapy | 1 | 2011 | 298 | 0.320 |
Why?
|
Sodium Channels | 1 | 2011 | 334 | 0.320 |
Why?
|
Dystonia | 1 | 2013 | 376 | 0.320 |
Why?
|
Brain Diseases | 3 | 2016 | 1551 | 0.320 |
Why?
|
Stereotypic Movement Disorder | 1 | 2009 | 31 | 0.320 |
Why?
|
Patient Care Team | 1 | 2020 | 2513 | 0.320 |
Why?
|
Stereotaxic Techniques | 4 | 2024 | 551 | 0.310 |
Why?
|
Craniocerebral Trauma | 1 | 2013 | 493 | 0.310 |
Why?
|
Lesch-Nyhan Syndrome | 1 | 2008 | 17 | 0.310 |
Why?
|
Dystonic Disorders | 1 | 2013 | 353 | 0.300 |
Why?
|
Famous Persons | 1 | 2009 | 108 | 0.300 |
Why?
|
Mental Disorders | 4 | 2021 | 6872 | 0.290 |
Why?
|
Food, Formulated | 1 | 2008 | 103 | 0.280 |
Why?
|
Functional Laterality | 7 | 2023 | 2243 | 0.280 |
Why?
|
Status Epilepticus | 4 | 2018 | 459 | 0.270 |
Why?
|
Spinal Puncture | 2 | 2006 | 284 | 0.270 |
Why?
|
Central Nervous System | 1 | 2014 | 1342 | 0.270 |
Why?
|
Uveitis | 1 | 2010 | 398 | 0.260 |
Why?
|
Health Personnel | 1 | 2020 | 3386 | 0.260 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2009 | 279 | 0.260 |
Why?
|
Pyridoxal Phosphate | 5 | 2017 | 123 | 0.260 |
Why?
|
DNA Mutational Analysis | 2 | 2014 | 4110 | 0.250 |
Why?
|
Fatal Outcome | 3 | 2018 | 1834 | 0.250 |
Why?
|
Patient Education as Topic | 2 | 2014 | 2331 | 0.250 |
Why?
|
Electrodes, Implanted | 3 | 2024 | 834 | 0.250 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3099 | 0.250 |
Why?
|
Autistic Disorder | 3 | 2004 | 1238 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3222 | 0.250 |
Why?
|
Rare Diseases | 2 | 2021 | 629 | 0.250 |
Why?
|
Vagus Nerve | 1 | 2008 | 458 | 0.240 |
Why?
|
Databases, Factual | 3 | 2021 | 8062 | 0.240 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2008 | 263 | 0.240 |
Why?
|
Language Development Disorders | 3 | 2020 | 194 | 0.240 |
Why?
|
Sarcoidosis | 1 | 2010 | 534 | 0.230 |
Why?
|
Metabolic Networks and Pathways | 2 | 2020 | 798 | 0.230 |
Why?
|
Carnosine | 1 | 2004 | 6 | 0.230 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3412 | 0.230 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2010 | 952 | 0.230 |
Why?
|
Treatment Outcome | 22 | 2024 | 65223 | 0.230 |
Why?
|
Muscle Hypotonia | 2 | 2020 | 166 | 0.230 |
Why?
|
Educational Measurement | 1 | 2011 | 1258 | 0.220 |
Why?
|
Landau-Kleffner Syndrome | 1 | 2003 | 10 | 0.220 |
Why?
|
Median Nerve | 1 | 2024 | 132 | 0.210 |
Why?
|
Polysomnography | 2 | 2009 | 1868 | 0.210 |
Why?
|
Ataxia | 2 | 2020 | 307 | 0.210 |
Why?
|
Age of Onset | 8 | 2021 | 3341 | 0.210 |
Why?
|
Retrospective Studies | 37 | 2024 | 81505 | 0.210 |
Why?
|
Movement Disorders | 2 | 2024 | 460 | 0.210 |
Why?
|
Needles | 1 | 2006 | 460 | 0.210 |
Why?
|
Sleep Deprivation | 1 | 2009 | 849 | 0.210 |
Why?
|
Aquaporin 4 | 1 | 2023 | 161 | 0.210 |
Why?
|
Cerebellar Diseases | 2 | 2018 | 227 | 0.200 |
Why?
|
Language | 7 | 2023 | 1550 | 0.200 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2024 | 240 | 0.200 |
Why?
|
Disease Models, Animal | 11 | 2024 | 18289 | 0.200 |
Why?
|
Biotin | 1 | 2023 | 257 | 0.200 |
Why?
|
Telemedicine | 3 | 2020 | 3106 | 0.200 |
Why?
|
Adult | 41 | 2024 | 223055 | 0.200 |
Why?
|
Uric Acid | 1 | 2008 | 808 | 0.200 |
Why?
|
Laryngostenosis | 1 | 2023 | 168 | 0.190 |
Why?
|
Complementary Therapies | 1 | 2005 | 486 | 0.190 |
Why?
|
Carboxy-Lyases | 1 | 2021 | 85 | 0.190 |
Why?
|
GABA Antagonists | 1 | 2021 | 120 | 0.180 |
Why?
|
Mutation | 7 | 2021 | 30188 | 0.180 |
Why?
|
Congenital Disorders of Glycosylation | 1 | 2001 | 51 | 0.180 |
Why?
|
Referral and Consultation | 1 | 2014 | 3614 | 0.180 |
Why?
|
Enzyme Replacement Therapy | 1 | 2021 | 80 | 0.180 |
Why?
|
Language Disorders | 3 | 2007 | 140 | 0.180 |
Why?
|
Human Rights Abuses | 1 | 2020 | 34 | 0.180 |
Why?
|
Aicardi Syndrome | 1 | 2020 | 16 | 0.170 |
Why?
|
Central Nervous System Stimulants | 3 | 2003 | 1167 | 0.170 |
Why?
|
Governing Board | 1 | 2020 | 50 | 0.170 |
Why?
|
Rett Syndrome | 2 | 2019 | 163 | 0.170 |
Why?
|
Organophosphorus Compounds | 1 | 2021 | 209 | 0.170 |
Why?
|
Awards and Prizes | 1 | 2024 | 364 | 0.170 |
Why?
|
Education, Medical, Graduate | 1 | 2012 | 2418 | 0.170 |
Why?
|
Synaptic Transmission | 2 | 2024 | 1175 | 0.170 |
Why?
|
Quality of Life | 1 | 2021 | 13466 | 0.170 |
Why?
|
Arginine | 2 | 2020 | 933 | 0.160 |
Why?
|
Deep Brain Stimulation | 1 | 2008 | 848 | 0.160 |
Why?
|
RNA Splice Sites | 1 | 2020 | 212 | 0.160 |
Why?
|
Intracranial Hypertension | 1 | 2021 | 190 | 0.160 |
Why?
|
Neurosurgical Procedures | 2 | 2020 | 2077 | 0.160 |
Why?
|
Aspartic Acid | 1 | 2001 | 575 | 0.160 |
Why?
|
Positron-Emission Tomography | 3 | 2011 | 6545 | 0.150 |
Why?
|
Neurophysiology | 2 | 2016 | 145 | 0.150 |
Why?
|
Facies | 2 | 2018 | 223 | 0.150 |
Why?
|
Frameshift Mutation | 1 | 2020 | 392 | 0.150 |
Why?
|
Epilepsy, Complex Partial | 2 | 2009 | 59 | 0.150 |
Why?
|
Germany | 1 | 2021 | 882 | 0.150 |
Why?
|
Neonatal Screening | 2 | 2013 | 619 | 0.150 |
Why?
|
Critical Care | 3 | 2021 | 2708 | 0.150 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4391 | 0.150 |
Why?
|
Physicians, Women | 1 | 2024 | 512 | 0.150 |
Why?
|
Cognition | 4 | 2022 | 7045 | 0.150 |
Why?
|
Animals | 23 | 2024 | 168730 | 0.150 |
Why?
|
Sleep | 4 | 2023 | 4819 | 0.150 |
Why?
|
Headache | 1 | 2006 | 1261 | 0.150 |
Why?
|
Neurologic Examination | 1 | 2001 | 913 | 0.150 |
Why?
|
Pregnant Women | 1 | 2023 | 575 | 0.150 |
Why?
|
Comprehension | 2 | 2015 | 636 | 0.140 |
Why?
|
Students, Medical | 1 | 2011 | 1962 | 0.140 |
Why?
|
Cerebral Cortex | 5 | 2019 | 5764 | 0.140 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2019 | 184 | 0.140 |
Why?
|
Heterozygote | 3 | 2020 | 2795 | 0.140 |
Why?
|
Plasma | 1 | 2020 | 579 | 0.140 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2023 | 3677 | 0.140 |
Why?
|
KCNQ2 Potassium Channel | 1 | 2017 | 19 | 0.140 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1678 | 0.140 |
Why?
|
Diagnosis, Differential | 7 | 2017 | 12966 | 0.140 |
Why?
|
Terminology as Topic | 1 | 2024 | 1536 | 0.140 |
Why?
|
GABA Modulators | 1 | 2017 | 108 | 0.140 |
Why?
|
Abortion, Induced | 1 | 2023 | 471 | 0.140 |
Why?
|
Energy Metabolism | 1 | 2008 | 2891 | 0.130 |
Why?
|
GABA Plasma Membrane Transport Proteins | 1 | 2016 | 30 | 0.130 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2008 | 2805 | 0.130 |
Why?
|
Consensus | 2 | 2024 | 3199 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2021 | 1187 | 0.130 |
Why?
|
Language Tests | 5 | 2012 | 191 | 0.130 |
Why?
|
Verbal Behavior | 3 | 2007 | 328 | 0.130 |
Why?
|
Myoclonus | 1 | 2017 | 107 | 0.130 |
Why?
|
Child Behavior | 1 | 2002 | 864 | 0.130 |
Why?
|
Electrophysiological Phenomena | 1 | 2018 | 308 | 0.130 |
Why?
|
Malformations of Cortical Development | 1 | 2018 | 174 | 0.130 |
Why?
|
Clinical Protocols | 1 | 2021 | 1438 | 0.130 |
Why?
|
Standard of Care | 1 | 2020 | 567 | 0.130 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2021 | 1145 | 0.130 |
Why?
|
Epilepsy, Generalized | 1 | 2018 | 182 | 0.120 |
Why?
|
Obsessive-Compulsive Disorder | 2 | 2020 | 1485 | 0.120 |
Why?
|
Laser Therapy | 1 | 2022 | 1109 | 0.120 |
Why?
|
Homozygote | 1 | 2020 | 1774 | 0.120 |
Why?
|
Corpus Callosum | 1 | 2020 | 751 | 0.120 |
Why?
|
Vesicular Transport Proteins | 1 | 2018 | 376 | 0.120 |
Why?
|
Clinical Competence | 1 | 2011 | 4860 | 0.120 |
Why?
|
Channelopathies | 1 | 2015 | 32 | 0.120 |
Why?
|
Focus Groups | 1 | 2021 | 1459 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 2427 | 0.120 |
Why?
|
Pitch Perception | 1 | 2015 | 100 | 0.120 |
Why?
|
Patient Care | 1 | 2020 | 629 | 0.120 |
Why?
|
Siblings | 1 | 2019 | 828 | 0.120 |
Why?
|
Seizures, Febrile | 1 | 2015 | 109 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 18064 | 0.110 |
Why?
|
United Arab Emirates | 1 | 2014 | 42 | 0.110 |
Why?
|
Longitudinal Studies | 3 | 2021 | 14745 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1084 | 0.110 |
Why?
|
MELAS Syndrome | 1 | 2014 | 54 | 0.110 |
Why?
|
Symbiosis | 1 | 2016 | 297 | 0.110 |
Why?
|
Myelin Sheath | 2 | 2008 | 652 | 0.110 |
Why?
|
Consciousness Disorders | 1 | 2017 | 445 | 0.100 |
Why?
|
Receptors, GABA-B | 1 | 2012 | 59 | 0.100 |
Why?
|
Internship and Residency | 1 | 2012 | 5944 | 0.100 |
Why?
|
Irritable Mood | 1 | 2013 | 196 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20680 | 0.100 |
Why?
|
Epilepsy, Absence | 2 | 2017 | 50 | 0.100 |
Why?
|
Age Factors | 6 | 2018 | 18380 | 0.100 |
Why?
|
Neuroendocrinology | 1 | 2011 | 5 | 0.090 |
Why?
|
Mice | 12 | 2024 | 81788 | 0.090 |
Why?
|
Benzodiazepines | 1 | 2017 | 1135 | 0.090 |
Why?
|
Video Recording | 1 | 2016 | 969 | 0.090 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2023 | 2027 | 0.090 |
Why?
|
Technology Assessment, Biomedical | 1 | 2014 | 312 | 0.090 |
Why?
|
Genetic Counseling | 1 | 2015 | 634 | 0.090 |
Why?
|
Prospective Studies | 8 | 2023 | 54798 | 0.090 |
Why?
|
Prognosis | 10 | 2024 | 29915 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2020 | 4255 | 0.090 |
Why?
|
Quality Control | 1 | 2014 | 835 | 0.090 |
Why?
|
History, 20th Century | 3 | 2012 | 2761 | 0.090 |
Why?
|
Encephalitis | 2 | 2017 | 440 | 0.090 |
Why?
|
Plants, Medicinal | 1 | 2011 | 165 | 0.090 |
Why?
|
Certification | 1 | 2014 | 419 | 0.090 |
Why?
|
Subthalamic Nucleus | 1 | 2013 | 203 | 0.090 |
Why?
|
Behavioral Medicine | 1 | 2011 | 49 | 0.090 |
Why?
|
Health Behavior | 1 | 2002 | 2649 | 0.090 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 1018 | 0.090 |
Why?
|
Disease Management | 2 | 2020 | 2532 | 0.090 |
Why?
|
Methylphenidate | 2 | 2005 | 480 | 0.090 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2017 | 855 | 0.090 |
Why?
|
Hodgkin Disease | 3 | 1993 | 1383 | 0.080 |
Why?
|
Follow-Up Studies | 8 | 2018 | 39226 | 0.080 |
Why?
|
Mitochondrial Diseases | 1 | 2013 | 344 | 0.080 |
Why?
|
Vision Disorders | 1 | 2017 | 1087 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2011 | 4772 | 0.080 |
Why?
|
Vitamin B 6 Deficiency | 1 | 2009 | 18 | 0.080 |
Why?
|
Nerve Net | 3 | 2008 | 2310 | 0.080 |
Why?
|
Karyotyping | 1 | 2011 | 1176 | 0.080 |
Why?
|
Central Nervous System Diseases | 1 | 2013 | 519 | 0.080 |
Why?
|
Glutamic Acid | 3 | 2011 | 1180 | 0.080 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1480 | 0.080 |
Why?
|
DNA, Mitochondrial | 1 | 2014 | 869 | 0.080 |
Why?
|
United States | 7 | 2023 | 72896 | 0.080 |
Why?
|
Autophagy | 1 | 2017 | 1352 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3656 | 0.080 |
Why?
|
Internationality | 1 | 2014 | 1005 | 0.080 |
Why?
|
Alanine | 1 | 2011 | 613 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26276 | 0.070 |
Why?
|
Carbon Radioisotopes | 1 | 2009 | 543 | 0.070 |
Why?
|
Scalp | 2 | 2022 | 388 | 0.070 |
Why?
|
Hippocampus | 1 | 2021 | 3774 | 0.070 |
Why?
|
Death, Sudden | 1 | 2010 | 301 | 0.070 |
Why?
|
Muscle Rigidity | 1 | 1988 | 41 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 1 | 2013 | 1118 | 0.070 |
Why?
|
Spine | 1 | 2015 | 1132 | 0.070 |
Why?
|
Remission, Spontaneous | 1 | 2008 | 384 | 0.070 |
Why?
|
Measles | 1 | 1990 | 180 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2057 | 0.070 |
Why?
|
Multifactorial Inheritance | 1 | 2016 | 1426 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2020 | 3425 | 0.070 |
Why?
|
Failure to Thrive | 1 | 2008 | 138 | 0.070 |
Why?
|
Infant, Premature | 1 | 2017 | 2120 | 0.070 |
Why?
|
Communication | 2 | 2020 | 3906 | 0.070 |
Why?
|
Preoperative Care | 3 | 2018 | 2244 | 0.070 |
Why?
|
Comorbidity | 2 | 2021 | 10570 | 0.070 |
Why?
|
Psychophysiologic Disorders | 1 | 2009 | 222 | 0.070 |
Why?
|
Electrodes | 2 | 2022 | 609 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2021 | 2891 | 0.070 |
Why?
|
Cohort Studies | 6 | 2021 | 41643 | 0.070 |
Why?
|
History, 19th Century | 1 | 2009 | 711 | 0.070 |
Why?
|
Computer Simulation | 1 | 2020 | 6252 | 0.070 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1739 | 0.070 |
Why?
|
Middle Aged | 20 | 2024 | 223016 | 0.070 |
Why?
|
Preoperative Period | 2 | 2020 | 564 | 0.070 |
Why?
|
Genetic Testing | 2 | 2020 | 3590 | 0.070 |
Why?
|
Behavioral Symptoms | 1 | 2008 | 187 | 0.070 |
Why?
|
Proteins | 1 | 2021 | 5996 | 0.070 |
Why?
|
Time Factors | 7 | 2017 | 40109 | 0.060 |
Why?
|
Recreation | 1 | 2006 | 124 | 0.060 |
Why?
|
Neurosciences | 1 | 2011 | 385 | 0.060 |
Why?
|
Arm | 1 | 2009 | 589 | 0.060 |
Why?
|
Equipment Failure | 1 | 2008 | 579 | 0.060 |
Why?
|
Predictive Value of Tests | 6 | 2021 | 15398 | 0.060 |
Why?
|
Models, Biological | 4 | 2012 | 9441 | 0.060 |
Why?
|
Globus Pallidus | 2 | 2003 | 248 | 0.060 |
Why?
|
Folic Acid Deficiency | 1 | 2005 | 117 | 0.060 |
Why?
|
Diet | 1 | 2023 | 8085 | 0.060 |
Why?
|
Fluorescein Angiography | 1 | 2010 | 1050 | 0.060 |
Why?
|
Awareness | 1 | 2009 | 653 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12122 | 0.060 |
Why?
|
Mouth | 1 | 1987 | 382 | 0.060 |
Why?
|
Psychophysiology | 1 | 2004 | 136 | 0.060 |
Why?
|
Biogenic Monoamines | 1 | 2004 | 50 | 0.060 |
Why?
|
Adaptation, Psychological | 2 | 2006 | 2662 | 0.060 |
Why?
|
Reproducibility of Results | 6 | 2023 | 20131 | 0.060 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 326 | 0.060 |
Why?
|
Temporal Lobe | 2 | 2009 | 1715 | 0.060 |
Why?
|
Diabetes Insipidus | 1 | 2004 | 143 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2006 | 326 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15881 | 0.050 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2004 | 348 | 0.050 |
Why?
|
Family Health | 1 | 2008 | 1253 | 0.050 |
Why?
|
Parent-Child Relations | 1 | 2008 | 774 | 0.050 |
Why?
|
Dominance, Cerebral | 1 | 2004 | 616 | 0.050 |
Why?
|
Glutamate Decarboxylase | 1 | 2004 | 239 | 0.050 |
Why?
|
Personhood | 1 | 2023 | 31 | 0.050 |
Why?
|
Analysis of Variance | 4 | 2017 | 6204 | 0.050 |
Why?
|
Evoked Potentials | 1 | 2009 | 1048 | 0.050 |
Why?
|
Catheterization, Central Venous | 1 | 2008 | 538 | 0.050 |
Why?
|
Hospital Mortality | 1 | 2017 | 5338 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2009 | 1409 | 0.050 |
Why?
|
Cytogenetics | 1 | 2003 | 197 | 0.050 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2003 | 71 | 0.050 |
Why?
|
Neural Conduction | 1 | 2024 | 442 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2011 | 14445 | 0.050 |
Why?
|
Brain Chemistry | 2 | 2003 | 952 | 0.050 |
Why?
|
Electromagnetic Phenomena | 1 | 2023 | 159 | 0.050 |
Why?
|
Syndrome | 2 | 2005 | 3269 | 0.050 |
Why?
|
Limbic System | 1 | 2004 | 418 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 1993 | 2968 | 0.050 |
Why?
|
Child Care | 1 | 2003 | 126 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2010 | 9548 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2022 | 9069 | 0.040 |
Why?
|
Neuronavigation | 1 | 2022 | 170 | 0.040 |
Why?
|
Tuberous Sclerosis | 2 | 2020 | 1039 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2003 | 624 | 0.040 |
Why?
|
Genotype | 3 | 2023 | 13023 | 0.040 |
Why?
|
Attitude to Health | 2 | 2008 | 2019 | 0.040 |
Why?
|
Putamen | 1 | 2021 | 289 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2780 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 1987 | 1475 | 0.040 |
Why?
|
Protein C Deficiency | 1 | 1999 | 25 | 0.040 |
Why?
|
Reaction Time | 2 | 2024 | 2086 | 0.040 |
Why?
|
Nervous System | 1 | 2003 | 542 | 0.040 |
Why?
|
Dopamine | 2 | 2023 | 1583 | 0.040 |
Why?
|
Chromosome Deletion | 1 | 2004 | 1385 | 0.040 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 1999 | 37 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2021 | 1606 | 0.040 |
Why?
|
Prednisolone | 1 | 2020 | 323 | 0.040 |
Why?
|
Education, Medical | 1 | 2011 | 1746 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2002 | 1006 | 0.040 |
Why?
|
Hyperthyroidism | 1 | 2001 | 293 | 0.040 |
Why?
|
Base Sequence | 1 | 2010 | 12402 | 0.040 |
Why?
|
Spectrum Analysis | 1 | 2021 | 443 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 10723 | 0.040 |
Why?
|
Sleep, REM | 1 | 2002 | 593 | 0.040 |
Why?
|
Reading | 1 | 2002 | 540 | 0.040 |
Why?
|
Cross-Over Studies | 2 | 2021 | 2108 | 0.040 |
Why?
|
Lasers | 1 | 2022 | 951 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2020 | 618 | 0.040 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2002 | 626 | 0.040 |
Why?
|
Neuroprotective Agents | 1 | 2005 | 958 | 0.040 |
Why?
|
Serotonin | 1 | 2003 | 1047 | 0.040 |
Why?
|
Videoconferencing | 1 | 2020 | 209 | 0.040 |
Why?
|
Ethics, Medical | 1 | 2023 | 784 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2020 | 540 | 0.040 |
Why?
|
Curriculum | 1 | 2011 | 3780 | 0.040 |
Why?
|
Myoclonic Epilepsy, Juvenile | 1 | 2017 | 13 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 16040 | 0.030 |
Why?
|
Risk Factors | 4 | 2021 | 74853 | 0.030 |
Why?
|
Protein Binding | 1 | 2009 | 9297 | 0.030 |
Why?
|
Bipolar Disorder | 2 | 2006 | 5127 | 0.030 |
Why?
|
Hospital Units | 1 | 2018 | 142 | 0.030 |
Why?
|
Amino Acids | 1 | 2023 | 1709 | 0.030 |
Why?
|
Abnormalities, Multiple | 1 | 2004 | 1424 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2001 | 748 | 0.030 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2017 | 152 | 0.030 |
Why?
|
Oscillometry | 1 | 2016 | 151 | 0.030 |
Why?
|
Models, Molecular | 2 | 2016 | 5377 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2001 | 665 | 0.030 |
Why?
|
Histidine | 1 | 2017 | 301 | 0.030 |
Why?
|
Cholinergic Antagonists | 1 | 2017 | 165 | 0.030 |
Why?
|
Lactic Acid | 1 | 2001 | 1137 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2012 | 8927 | 0.030 |
Why?
|
Radiopharmaceuticals | 3 | 2016 | 2700 | 0.030 |
Why?
|
Hashimoto Disease | 1 | 2017 | 109 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2023 | 1270 | 0.030 |
Why?
|
Dogs | 1 | 2020 | 3824 | 0.030 |
Why?
|
Fetus | 1 | 2023 | 1878 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1994 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4587 | 0.030 |
Why?
|
Neuronal Plasticity | 3 | 2009 | 1444 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2012 | 1527 | 0.030 |
Why?
|
Neuropsychological Tests | 3 | 2017 | 7119 | 0.030 |
Why?
|
Prolactin | 1 | 2017 | 625 | 0.030 |
Why?
|
Monitoring, Ambulatory | 1 | 2018 | 357 | 0.030 |
Why?
|
Logistic Models | 2 | 2021 | 13266 | 0.030 |
Why?
|
Dopamine Agonists | 1 | 2017 | 346 | 0.030 |
Why?
|
Evoked Potentials, Visual | 1 | 2017 | 419 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1587 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1432 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2007 | 3359 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2719 | 0.030 |
Why?
|
Health Resources | 1 | 2020 | 949 | 0.030 |
Why?
|
Length of Stay | 2 | 2018 | 6485 | 0.030 |
Why?
|
Respiration Disorders | 1 | 2017 | 364 | 0.030 |
Why?
|
Risk | 1 | 2005 | 9600 | 0.030 |
Why?
|
Equipment and Supplies | 1 | 2016 | 273 | 0.030 |
Why?
|
Dementia | 1 | 1988 | 2743 | 0.030 |
Why?
|
Intensive Care Units | 2 | 2017 | 3799 | 0.030 |
Why?
|
GABA-B Receptor Antagonists | 1 | 2012 | 11 | 0.030 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2013 | 115 | 0.030 |
Why?
|
Prevalence | 2 | 2023 | 15832 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2008 | 4528 | 0.030 |
Why?
|
Body Temperature | 1 | 2016 | 781 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2017 | 869 | 0.030 |
Why?
|
Parents | 2 | 2003 | 3590 | 0.020 |
Why?
|
Cephalometry | 1 | 2013 | 380 | 0.020 |
Why?
|
Cysteine | 1 | 2017 | 898 | 0.020 |
Why?
|
Atrophy | 2 | 2010 | 1629 | 0.020 |
Why?
|
Phenytoin | 1 | 2012 | 189 | 0.020 |
Why?
|
Attention | 1 | 2002 | 2415 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2018 | 1456 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1331 | 0.020 |
Why?
|
Physical Examination | 1 | 2017 | 1263 | 0.020 |
Why?
|
District of Columbia | 1 | 2011 | 159 | 0.020 |
Why?
|
Health Promotion | 1 | 2003 | 2208 | 0.020 |
Why?
|
Vaccination | 1 | 2003 | 3425 | 0.020 |
Why?
|
Hypothermia, Induced | 1 | 2016 | 754 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2002 | 2595 | 0.020 |
Why?
|
Glasgow Coma Scale | 1 | 2012 | 574 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1393 | 0.020 |
Why?
|
Aldehydes | 1 | 2011 | 169 | 0.020 |
Why?
|
Cell Line | 1 | 2024 | 15540 | 0.020 |
Why?
|
Primary Health Care | 2 | 2005 | 4735 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 9520 | 0.020 |
Why?
|
North America | 1 | 2013 | 1285 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2016 | 1993 | 0.020 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2013 | 390 | 0.020 |
Why?
|
Point Mutation | 1 | 2014 | 1590 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2020 | 13402 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2011 | 699 | 0.020 |
Why?
|
Patient Compliance | 2 | 2012 | 2693 | 0.020 |
Why?
|
Depression | 1 | 2008 | 8224 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6408 | 0.020 |
Why?
|
Stroke | 2 | 2001 | 9749 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1639 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8725 | 0.020 |
Why?
|
Laparotomy | 1 | 1990 | 460 | 0.020 |
Why?
|
Radiography | 2 | 2010 | 6941 | 0.020 |
Why?
|
Saliva | 1 | 2012 | 851 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14644 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12421 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 30215 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 1990 | 433 | 0.020 |
Why?
|
Creatinine | 1 | 2012 | 1916 | 0.020 |
Why?
|
Carotid Artery Injuries | 1 | 1987 | 96 | 0.020 |
Why?
|
Intelligence Tests | 1 | 2007 | 504 | 0.020 |
Why?
|
Retina | 1 | 2017 | 2648 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1194 | 0.020 |
Why?
|
History, 21st Century | 1 | 2012 | 1573 | 0.020 |
Why?
|
Anemia, Hemolytic | 1 | 1987 | 164 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2194 | 0.020 |
Why?
|
Random Allocation | 1 | 2010 | 2394 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2008 | 947 | 0.020 |
Why?
|
Protein Kinases | 1 | 2012 | 1611 | 0.020 |
Why?
|
Parasomnias | 1 | 2005 | 27 | 0.020 |
Why?
|
Hypoventilation | 1 | 2005 | 44 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9653 | 0.010 |
Why?
|
Glomerulonephritis | 1 | 1987 | 331 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2219 | 0.010 |
Why?
|
Ethiodized Oil | 1 | 1984 | 26 | 0.010 |
Why?
|
Neurons | 1 | 2023 | 9521 | 0.010 |
Why?
|
Tamoxifen | 1 | 1989 | 965 | 0.010 |
Why?
|
Homovanillic Acid | 1 | 2003 | 73 | 0.010 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2003 | 94 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12056 | 0.010 |
Why?
|
Semantics | 1 | 2007 | 609 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 2003 | 289 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10607 | 0.010 |
Why?
|
Tics | 1 | 2003 | 76 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6014 | 0.010 |
Why?
|
Carotid Arteries | 1 | 1987 | 937 | 0.010 |
Why?
|
Narcolepsy | 1 | 2005 | 200 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1987 | 616 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22323 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5368 | 0.010 |
Why?
|
Spleen | 1 | 1988 | 2296 | 0.010 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 1989 | 920 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5302 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 1166 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12800 | 0.010 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2005 | 597 | 0.010 |
Why?
|
Hallucinations | 1 | 2003 | 373 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8320 | 0.010 |
Why?
|
Social Behavior | 1 | 2006 | 1143 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 2003 | 967 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10087 | 0.010 |
Why?
|
Speech Perception | 1 | 2004 | 512 | 0.010 |
Why?
|
Drug Resistance | 1 | 2005 | 1590 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2006 | 1510 | 0.010 |
Why?
|
Glycine | 1 | 2003 | 671 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13613 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 1987 | 1171 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2005 | 1308 | 0.010 |
Why?
|
Reference Values | 1 | 2005 | 4911 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2004 | 2511 | 0.010 |
Why?
|
Pedigree | 1 | 2005 | 4528 | 0.010 |
Why?
|
Hospitalization | 1 | 2018 | 10803 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3794 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2350 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2012 | 59506 | 0.010 |
Why?
|
Anorexia Nervosa | 1 | 2005 | 1328 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8039 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6304 | 0.010 |
Why?
|
Teaching | 1 | 2003 | 1170 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 4249 | 0.010 |
Why?
|
Liver | 2 | 1988 | 7558 | 0.010 |
Why?
|
Alcoholism | 1 | 2005 | 1977 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6061 | 0.010 |
Why?
|
Neural Pathways | 1 | 2005 | 3087 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 1987 | 1943 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2004 | 2674 | 0.010 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2003 | 1102 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2002 | 1883 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 24278 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23588 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1984 | 2327 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 22227 | 0.010 |
Why?
|
Aged | 3 | 2012 | 171178 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1984 | 4351 | 0.000 |
Why?
|
Granuloma | 1 | 1988 | 329 | 0.000 |
Why?
|
Kidney Glomerulus | 1 | 1987 | 567 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1989 | 13446 | 0.000 |
Why?
|
Intestine, Small | 1 | 1990 | 1216 | 0.000 |
Why?
|
Radiotherapy | 1 | 1990 | 1493 | 0.000 |
Why?
|
Remission Induction | 1 | 1989 | 2410 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1989 | 21064 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1989 | 2884 | 0.000 |
Why?
|
Menopause | 1 | 1989 | 1661 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1990 | 8529 | 0.000 |
Why?
|
Acute Disease | 1 | 1987 | 7237 | 0.000 |
Why?
|
Recurrence | 1 | 1988 | 8506 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1990 | 11205 | 0.000 |
Why?
|